Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study

1. Bellmunt, J.
2. Maroto, P.
3. Bonfill, T.
4. Vazquez, F.
5. Perez-Gracia, J.L.
6. Juanpere, N.
7. Hernandez-Prat, A.
8. Hernandez-Llodra, S.
9. Rovira, A.
10. Juan, O.
11. Rodriguez-Vida, A.